Xenon Pharmaceuticals Inc. - Common Shares (XENE)

Xenon Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of innovative therapeutics for neurological disorders and other serious conditions

Utilizing its proprietary gene modulation platform, the company aims to identify and advance novel drug candidates that target the underlying causes of diseases rather than merely addressing symptoms. By leveraging its expertise in genetic insights and biochemical pathways, Xenon strives to improve patient outcomes through precision medicine, building a robust pipeline of potential treatments for conditions such as epilepsy and other central nervous system disorders.